Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IES Holdings (IESC) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for IES Holdings (IESC) over the last 17 years, with Q4 2025 value amounting to $158000.0.

  • IES Holdings' Asset Writedowns and Impairment fell 2977.78% to $158000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $3.4 million, marking a year-over-year increase of 11709.51%. This contributed to the annual value of $3.4 million for FY2025, which is 13261.31% up from last year.
  • As of Q4 2025, IES Holdings' Asset Writedowns and Impairment stood at $158000.0, which was down 2977.78% from $2.8 million recorded in Q3 2025.
  • Over the past 5 years, IES Holdings' Asset Writedowns and Impairment peaked at $2.8 million during Q3 2025, and registered a low of -$600000.0 during Q3 2023.
  • In the last 5 years, IES Holdings' Asset Writedowns and Impairment had a median value of $225000.0 in 2024 and averaged $499421.1.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first surged by 1103333.33% in 2022, then plummeted by 24117.65% in 2023.
  • Quarter analysis of 5 years shows IES Holdings' Asset Writedowns and Impairment stood at $92000.0 in 2021, then plummeted by 31.52% to $63000.0 in 2022, then soared by 138.1% to $150000.0 in 2023, then skyrocketed by 50.0% to $225000.0 in 2024, then dropped by 29.78% to $158000.0 in 2025.
  • Its Asset Writedowns and Impairment stands at $158000.0 for Q4 2025, versus $2.8 million for Q3 2025 and $414000.0 for Q2 2025.